The SWIFT trial, led by Dr Jeffrey L Saver (University of California, Los Angeles), pitted the Solitaire device against the Merci retriever in 113 patients with acute ischemic stroke from 18 centers ...

When a person is having an acute stroke, every minute of delayed treatment means a higher risk of permanent brain damage. A new procedure, available at UNC Hospitals, hopes to increases a person’s ...

At present, tissue plasminogen activator (t-PA) is the only drug approved by the US Food and Drug Administration (FDA) for use in the treatment of acute ischemic stroke. Since the approval of t-PA in ...

Dr. J.P. Wensel used to get frustrated treating stroke patients. Sometimes they died because the chemical treatments available did not dissolve their blood clots fast enough -- or even at all. The ...

Upbeat phase III findings outweighed less encouraging late-stage trial news, as big pharma provided a mixed bag of cancer findings – with one data batch to form... Apple Inc., of Cupertino, Calif., ...